Related Experiment Video
Updated: Jun 28, 2025
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations
Meng Guan1, Shuhan Liu1, Yong-Guang Yang2
1Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin 130021, China; Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Abstract:
Over the past few decades, significant strides have been made in understanding the pivotal roles that chemokine networks play in tumor biology. These networks, comprising chemokines and their receptors, wield substantial influence over cancer immune regulation and therapeutic outcomes. As a result, targeting these chemokine systems has emerged as a promising avenue for cancer immunotherapy. However, therapies targeting chemokines face significant challenges in solid tumor treatment, due to the complex and fragile of the chemokine networks. A nuanced comprehension of the complicacy and functions of chemokine networks, and their impact on the tumor microenvironment, is essential for optimizing their therapeutic utility in oncology. This review elucidates the ways in which chemokine networks interact with cancer immunity and tumorigenesis. We particularly elaborate on recent innovations in manipulating these networks for cancer treatment. The review also highlights future challenges and explores potential biomaterial strategies for clinical applications.
Insights
Chemokine networks are crucial in cancer immunity and tumor growth. Targeting these systems offers potential for cancer immunotherapy, but challenges remain in understanding their complex roles in the tumor microenvironment.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Chemokine networks significantly influence cancer immune regulation and therapeutic outcomes.
- Targeting chemokine systems is a promising strategy for cancer immunotherapy.
- The complexity of chemokine networks presents challenges for solid tumor treatment.
Purpose of the Study:
- To elucidate the interaction between chemokine networks, cancer immunity, and tumorigenesis.
- To review recent innovations in manipulating chemokine networks for cancer treatment.
- To explore future challenges and biomaterial strategies for clinical applications.
Main Methods:
- Literature review focusing on chemokine networks in cancer biology.
- Analysis of the impact of chemokine networks on the tumor microenvironment.
- Discussion of current and emerging therapeutic strategies.
Main Results:
- Chemokine networks play a pivotal role in modulating the tumor microenvironment.
- Understanding chemokine network complexity is essential for effective cancer therapy.
- Recent innovations show promise in manipulating these networks for treatment.
Conclusions:
- Further research into chemokine network intricacies is vital for advancing cancer immunotherapy.
- Biomaterial strategies may offer novel approaches for clinical applications.
- Overcoming challenges in targeting chemokine systems is key to improving cancer treatment outcomes.
More Related Videos
Related Concept Videos
02:17The Tumor Microenvironment
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Tumor Immunotherapy
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...